BioSyent, Inc. (RX.V)
15.55
-0.15
(-0.96%)
CAD |
TSXV |
Aug 26, 11:44
BioSyent Total Assets (Quarterly) : 60.46M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 60.46M |
| March 31, 2026 | 62.49M |
| December 31, 2025 | 49.44M |
| September 30, 2025 | 47.79M |
| June 30, 2025 | 43.50M |
| March 31, 2025 | 42.76M |
| December 31, 2024 | 41.36M |
| September 30, 2024 | 45.47M |
| June 30, 2024 | 41.48M |
| March 31, 2024 | 40.00M |
| December 31, 2023 | 41.53M |
| September 30, 2023 | 41.40M |
| June 30, 2023 | 39.51M |
| March 31, 2023 | 38.75M |
| December 31, 2022 | 40.49M |
| September 30, 2022 | 39.02M |
| June 30, 2022 | 37.98M |
| March 31, 2022 | 37.87M |
| December 31, 2021 | 37.17M |
| September 30, 2021 | 37.33M |
| June 30, 2021 | 34.34M |
| March 31, 2021 | 33.25M |
| December 31, 2020 | 33.57M |
| September 30, 2020 | 31.88M |
| June 30, 2020 | 30.55M |
| Date | Value |
|---|---|
| March 31, 2020 | 31.14M |
| December 31, 2019 | 30.97M |
| September 30, 2019 | 30.02M |
| June 30, 2019 | 28.04M |
| March 31, 2019 | 30.02M |
| December 31, 2018 | 31.19M |
| September 30, 2018 | 29.37M |
| June 30, 2018 | 28.31M |
| March 31, 2018 | 25.93M |
| December 31, 2017 | 25.10M |
| September 30, 2017 | 23.03M |
| June 30, 2017 | 21.72M |
| March 31, 2017 | 19.81M |
| December 31, 2016 | 19.25M |
| September 30, 2016 | 17.30M |
| June 30, 2016 | 16.37M |
| March 31, 2016 | 14.66M |
| December 31, 2015 | 14.61M |
| September 30, 2015 | 13.32M |
| June 30, 2015 | 11.93M |
| March 31, 2015 | 10.88M |
| December 31, 2014 | 10.64M |
| September 30, 2014 | 9.183M |
| June 30, 2014 | 7.637M |
| March 31, 2014 | 6.417M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | 182.38M |
| Bausch Health Cos., Inc. | 35.18B |
| Cipher Pharmaceuticals, Inc. | 222.59M |
| Revive Therapeutics Ltd. | 0.2818M |
| Knight Therapeutics, Inc. | 1.045B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.62M |
| Shareholders Equity (Quarterly) | 45.84M |
| Debt to Equity Ratio | 0.0685 |
| Current Ratio | 2.068 |
| Net Debt Paydown Yield | -0.26% |